ENO1 and hepatocellular carcinoma: This combined clinical diagnostic utility of ENO1 and CA19-9 has also been reported previously for the detection of endometriosis [157], whereas ENO1 alone has been demonstrated to be a reliable diagnostic marker and independent prognostic marker for overall survival in hepatocellular carcinoma patients [158,159].